← FDA Drug Approvals (Drugs@FDA)

CLOFARABINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 2018-12-27

Drug application

FDA Application #

ANDA210283

Application type

Abbreviated New Drug Application (Generic)

Brand name

CLOFARABINE

Generic name

Clofarabine

Active ingredients

CLOFARABINE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

HOSPIRA

First approval

2018-12-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown